Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03308396
Title Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ajjai Alva, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.